Cubist Systematic Strategies, LLC Aurinia Pharmaceuticals Inc. Transaction History

Cubist Systematic Strategies, LLC

  • $15.8 Billion
  • Q3 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 20,409 shares of AUPH stock, worth $183,272. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,409
Holding current value
$183,272
% of portfolio
0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$5.32 - $7.33 $108,575 - $149,597
20,409 New
20,409 $149,000
Q4 2023

Feb 14, 2024
BUY
$7.13 - $9.49 $631,874 - $841,022
88,622 New
88,622 $796,000
Q2 2023

Aug 14, 2023
SELL
$8.96 - $11.69 $2.2 Million - $2.88 Million
-245,986 Reduced 90.76%
25,038 $242,000
Q1 2023

May 15, 2023
BUY
$5.94 - $11.27 $851,647 - $1.62 Million
143,375 Added 112.32%
271,024 $2.97 Million
Q4 2022

Feb 14, 2023
SELL
$4.11 - $8.14 $239,736 - $474,806
-58,330 Reduced 31.36%
127,649 $551,000
Q3 2022

Nov 14, 2022
BUY
$6.66 - $12.39 $1.24 Million - $2.3 Million
185,979 New
185,979 $1.4 Million
Q2 2022

Aug 15, 2022
SELL
$8.95 - $12.8 $2.46 Million - $3.51 Million
-274,374 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$10.05 - $22.48 $2.76 Million - $6.17 Million
274,374 New
274,374 $3.4 Million
Q2 2021

Aug 16, 2021
SELL
$10.0 - $14.52 $38,890 - $56,468
-3,889 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$12.3 - $18.73 $25,005 - $38,078
2,033 Added 109.54%
3,889 $50,000
Q4 2020

Feb 16, 2021
BUY
$12.94 - $16.05 $18,258 - $22,646
1,411 Added 317.08%
1,856 $26,000
Q3 2020

Nov 16, 2020
SELL
$13.19 - $16.66 $333,786 - $421,597
-25,306 Reduced 98.27%
445 $7,000
Q2 2020

Aug 14, 2020
SELL
$14.12 - $18.33 $121,940 - $158,297
-8,636 Reduced 25.11%
25,751 $418,000
Q1 2020

May 15, 2020
BUY
$11.34 - $21.46 $352,447 - $666,976
31,080 Added 939.82%
34,387 $499,000
Q4 2019

Feb 14, 2020
SELL
$3.88 - $21.42 $9,564 - $52,800
-2,465 Reduced 42.71%
3,307 $67,000
Q3 2019

Nov 14, 2019
BUY
$5.34 - $6.59 $28,686 - $35,401
5,372 Added 1343.0%
5,772 $31,000
Q2 2019

Aug 14, 2019
SELL
$6.05 - $6.75 $167,585 - $186,975
-27,700 Reduced 98.58%
400 $3,000
Q1 2019

May 15, 2019
BUY
$6.06 - $7.64 $48,480 - $61,120
8,000 Added 39.8%
28,100 $183,000
Q4 2018

Feb 14, 2019
BUY
$5.08 - $6.83 $102,108 - $137,283
20,100 New
20,100 $137,000
Q1 2018

May 15, 2018
SELL
$4.85 - $5.99 $16,839 - $20,797
-3,472 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$4.53 - $7.09 $15,728 - $24,616
3,472
3,472 $16,000

Others Institutions Holding AUPH

# of Institutions
207
Shares Held
58.6M
Call Options Held
1.14M
Put Options Held
1.51M
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.27B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email